The folding pathway of a1-antitrypsin: Avoiding the unavoidable

Proceedings of the American Thoracic Society

Volumn 7, Issue 6, 2010, Pages 404-407

  Bottomley, Stephen P ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Protein aggregation; Protein folding; Serpin; 1 antitrypsin

Indexed keywords

ALPHA 1 ANTITRYPSIN;

HUMAN; METABOLISM; PROTEIN FOLDING; REVIEW;

ALPHA 1-ANTITRYPSIN; HUMANS; PROTEIN FOLDING;

EID: 79952680796     PISSN: 15463222     EISSN: 19435665     Source Type: Journal    
DOI: 10.1513/pats.201004-031AW     Document Type: Conference Paper

References (40)

1. Whisstock JC, Bottomley SP. Molecular gymnastics: serpin structure, folding and misfolding. Curr Opin Struct Biol 2006;16:761-768.
2. Gooptu B, Lomas DA. Conformational pathology of the serpins: themes, variations, and therapeutic strategies. Annu Rev Biochem 2009;78:147-176.
3. Anfinsen CB. Principles that govern the folding of protein chains. Science 1973;181:223-230.
4. Cabrita LD, Bottomley SP. How do proteins avoid becoming too stable? Biophysical studies into metastable proteins. Eur Biophys J 2004;33: 83-88.
5. Irving JA, Pike RN, Lesk AM, Whisstock JC. Phylogeny of the serpin superfamily: implications of patterns of amino acid conservation for structure and function. Genome Res 2000;10:1841-1860.
6. Elliott PR, Abrahams JP, Lomas DA. Wild-type alpha 1-antitrypsin is in the canonical inhibitory conformation. J Mol Biol 1998;275:419-425.
7. Huntington JA, Read RJ, Carrell RW. Structure of a serpin-protease complex shows inhibition by deformation. Nature 2000;407:923-926.
8. Stratikos E, Gettins PG. Formation of the covalent serpin-proteinase complex involves translocation of the proteinase by more than 70 A and full insertion of the reactive center loop into beta-sheet A. Proc Natl Acad Sci USA 1999;96:4808-4813.
9. Tew DJ, Bottomley SP. Intrinsic fluorescence changes and rapid kinetics of proteinase deformation during serpin inhibition. FEBS Lett 2001; 494:30-33.
10. Bruch M, Weiss V, Engel J. Plasma serine proteinase inhibitors (serpins) exhibit major conformational changes and a large increase in conformational stability upon cleavage at their reactive sites. J Biol Chem 1988;263:16626-16630.
11. Powell LM, Pain RH. Effects of glycosylation on the folding and stability of human, recombinant and cleaved alpha 1-antitrypsin. J Mol Biol 1992;224:241-252.
12. Herve M, Ghelis C. Conformational changes in intact and papainmodified alpha 1-proteinase inhibitor induced by guanidinium chloride. Eur J Biochem 1990;191:653-658.
13. Loebermann H, Tokuoka R, Deisenhofer J, Huber R. Human alpha 1-proteinase inhibitor: crystal structure analysis of two crystal modifications, molecular model and preliminary analysis of the implications for function. J Mol Biol 1984;177:531-557.
14. Gooptu B, Hazes B, Chang WS, Dafforn TR, Carrell RW, Read RJ, Lomas DA. Inactive conformation of the serpin alpha(1)-antichymotrypsin indicates two-stage insertion of the reactive loop: implications for inhibitory function and conformational disease. Proc Natl Acad Sci USA 2000;97:67-72.
15. Whisstock J, Skinner R, Lesk AM. An atlas of serpin conformations. Trends Biochem Sci 1998;23:63-67.
16. Stein PE, Carrell RW. What do dysfunctional serpins tell us about molecular mobility and disease? Nat Struct Biol 1995;2:96-113.
17. Cabrita LD, Irving JA, Pearce MC, Whisstock JC, Bottomley SP. Aeropin from the extremophile Pyrobaculum aerophilum bypasses the serpin misfolding trap. J Biol Chem 2007;282:26802-26809.
18. Irving JA, Cabrita LD, Rossjohn J, Pike RN, Bottomley SP, Whisstock JC. The 1.5 a crystal structure of a prokaryote serpin: controlling conformational change in a heated environment. Structure 2003;11:387-397.
19. Pearce MC, Rubin H, Bottomley SP. Conformational change and intermediates in the unfolding of falphag1-antichymotrypsin. J Biol Chem 2000;275:28513-28518.
20. Zhang Q, Buckle AM, Law RH, Pearce MC, Cabrita LD, Lloyd GJ, Irving JA, Smith AI, Ruzyla K, Rossjohn J, et al. The N terminus of the serpin, tengpin, functions to trap the metastable native state. EMBO Rep 2007;8:658-663.
21. Eftink MR. The use of fluorescence methods to monitor unfolding transitions in proteins. Biophys J 1994;66:482-501.
22. James EL,Whisstock JC, GoreMG, Bottomley SP. Probing the unfolding pathway of alpha1-antitrypsin. J Biol Chem 1999;274:9482-9488.
23. Tew DJ, Bottomley SP. Probing the equilibrium denaturation of the serpin alpha(1)-antitrypsin with single tryptophan mutants; evidence for structure in the urea unfolded state. J Mol Biol 2001;313:1161-1169.
24. Cabrita LD, Dai W, Bottomley SP. Different conformational changes within the F-helix occur during serpin folding, polymerization, and proteinase inhibition. Biochemistry 2004;43:9834-9839.
25. Cabrita LD, Whisstock JC, Bottomley SP. Probing the role of the F-helix in serpin stability through a single tryptophan substitution. Biochemistry 2002;41:4575-4581.
26. Tsutsui Y,Wintrode PL. Cooperative unfolding of a metastable serpin to a molten globule suggests a link between functional and folding energy landscapes. J Mol Biol 2007;371:245-255.
27. Seo EJ, Im H, Maeng JS, Kim KE, Yu MH. Distribution of the native strain in human alpha 1-antitrypsin and its association with protease inhibitor function. J Biol Chem 2000;275:16904-16909.
28. Lee KN, Park SD, Yu MH. Probing the native strain iin alpha1-antitrypsin. Nat Struct Biol 1996;3:497-500.
29. Ryu SE, Choi HJ, Kwon KS, Lee KN, Yu MH. The native strains in the hydrophobic core and flexible reactive loop of a serine protease inhibitor: crystal structure of an uncleaved alpha1-antitrypsin at 2.7A . Structure 1996;4:1181-1192.
30. Im H, Seo EJ, Yu MH. Metastability in the inhibitory mechanism of human alpha1-antitrypsin. J Biol Chem 1999;274:11072-11077.
31. Lee C, Park SH, Lee MY, Yu MH. Regulation of protein function by native metastability. Proc Natl Acad Sci USA 2000;97: 7727-7731.
32. Im H, Woo MS, Hwang KY, Yu MH. Interactions causing the kinetic trap in serpin protein folding. J Biol Chem 2002;277:46347-46354.
33. Devlin GL, Bottomley SP. A protein family under 'stress'-serpin stability, folding and misfolding. Front Biosci 2005;10:288-299.
34. Mahadeva R, Lomas DA. Genetics and respiratory disease 2 Alpha 1-antitrypsin deficiency, cirrhosis and emphysema. Thorax 1998;53: 501-505.
35. Lomas DA, Evans DL, Finch JT, Carrell RW. The mechanism of Z alpha 1-antitrypsin accumulation in the liver. Nature 1992;357:605-607.
36. Lomas DA, Evans DL, Stone SR, Chang WS, Carrell RW. Effect of the Z mutation on the physical and inhibitory properties of alpha 1-antitrypsin. Biochemistry 1993;32:500-508.
37. Mahadeva R, Dafforn TR, Carrell RW, Lomas DA. 6-mer peptide selectively anneals to a pathogenic serpin conformation and blocks polymerization: implications for the prevention of z alpha(1)-antitrypsin-related cirrhosis. J Biol Chem 2002;277:6771-6774.
38. Knaupp AS, Levina V, Robertson AL, Pearce MC, Bottomley SP. Kinetic instability of the serpin Z alpha1-antitrypsin promotes aggregation. J Mol Biol 2010;396:375-383.
39. Yu MH, Lee KN, Kim J. The Z type variation of human alpha 1-antitrypsin causes a protein folding defect. Nat Struct Biol 1995;2: 363-367.
40. Dafforn TR, Mahadeva R, Elliott PR, Sivasothy P, Lomas DA. A kinetic mechanism for the polymerization of alpha1-antitrypsin. J Biol Chem 1999;274:9548-9555.